Ammonia N-13
Generic: AMMONIA N-13
Basic Information
Manufacturer
Cardinal Health 414, LLC
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS
FDA Set ID
4c563174-c7cd-4224-b865-4da2f39c21c0
Indications & Usage
1 INDICATIONS AND USAGE Ammonia N-13 Injection, USP is indicated for diagnostic Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease.
Ammonia N-13 Injection, USP is a radioactive diagnostic agent for Positron Emission Tomography (PET) indicated for diagnostic PET imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease ( 1 ).
Ammonia N-13 Injection, USP is a radioactive diagnostic agent for Positron Emission Tomography (PET) indicated for diagnostic PET imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease ( 1 ).
Adverse Reactions
6 ADVERSE REACTIONS No adverse reactions have been reported for Ammonia N-13 Injection, USP based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting systems.
However, the completeness of these sources is not known.
No adverse reactions have been reported for Ammonia N-13 Injection, USP based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting system ( 6 ).
To report SUSPECTED ADVERSE REACTIONS, contact Cardinal Health at 1-800-618-2768 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
However, the completeness of these sources is not known.
No adverse reactions have been reported for Ammonia N-13 Injection, USP based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting system ( 6 ).
To report SUSPECTED ADVERSE REACTIONS, contact Cardinal Health at 1-800-618-2768 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch